The chemotherapy induced anemia market is witnessing accelerated growth driven by rising cancer prevalence and advancements in therapeutics aimed at mitigating treatment-related side effects. Increasing emphasis on supportive care to enhance patient quality of life is fueling innovation and adoption of anemia management solutions. This dynamic environment underscores significant market...